Mathieu Klos

Cologne, Germany

Editor at Juve Patent

Analysis and commentary on the European patent law market by Mathieu Klos, Co-Editor https://t.co/qW8iJ0e82u.

Featured in: Favicon

juve-patent.com

Articles

Zaun's appeal unsuccessful in Brexit-related case against Praesidiad

4 days ago | juve-patent.com | Mathieu Klos

The ruling came swiftly. On Friday, the UK Court of Appeal dismissed Zaun’s appeal against a UK High Court ruling (case ID: [2024] EWHC 1549 (Pat)) just nine days after the hearing. The case concerns high-security fence posts used to protect facilities such as oil fields. The dispute began in March 2018 when Betafence, later renamed Praesidiad, sued competitor Zaun for infringement of Community design right RCD 127204-0001. Both companies manufacture high-security fences.
Boehringer Ingelheim fails in bid for PI at local division Lisbon

1 week ago | juve-patent.com | Mathieu Klos

The UPC local division in Lisbon is not among the busiest in terms of case numbers. But as a relatively unknown entity compared to the established German local divisions, Lisbon has gained a reputation as an interesting venue for preliminary injunctions. According to the UPC’s latest statistics, Lisbon has heard one infringement claim and two preliminary injunction cases. It has already ruled on both PI applications, rejecting them in each instance.
Kinexon challenges Ballinno's offside patent with help from Bardehle

1 week ago | juve-patent.com | Mathieu Klos

Ballinno’s EP 1 944 067 covers a “method and system for detecting an offside situation”. The technology analyses an audio signal to determine when a player kicks the ball, which a referee can then use to ascertain if another player was offside at that moment. Thus, EP 067 is an extension of the video assistant referee (VAR), albeit with its technology specifically applied to the offside rule.
ToolGen and Vertex focus battle over CRISPR/Cas therapy Casgevy in Europe

1 week ago | juve-patent.com | Mathieu Klos

Biotech companies have fought over CRISPR/Cas patents for years, primarily at patent offices around the world. Now the technology has reached civil courts. Months ago, Korean biotech company ToolGen announced it would file patent infringement suits against Vertex. ToolGen is targeting the first therapy using CRISPR/Cas technology.
Former Carpmaels partner to lead Mewburn Ellis' patent litigation push

1 week ago | juve-patent.com | Mathieu Klos

Balleny worked at Carpmaels & Ransford for ten years, most recently as equity partner, before leaving in December 2024. Her next move remained unknown for several months. Now, the life sciences patent litigator has joined Mewburn Ellis. Like Carpmaels, the firm is one of the UK’s leading practices for life sciences patents with a strong focus on patent attorney work. Unlike Balleny’s former firm, however, Mewburn Ellis has not historically maintained a large litigation practice.
UK Court of Appeal orders Apple to pay Optis more money in FRAND dispute

1 week ago | juve-patent.com | Mathieu Klos

Reuters reported that an Optis spokesperson welcomed the ruling, which they said “corrected a clearly flawed prior ruling and has made meaningful progress toward affirming the true value of our patents to Apple devices”. “We will continue to ensure fair compensation for the Optis intellectual property that enables high-speed connectivity for millions of devices around the world,” the spokesperson added.
Praesidiad vs Zaun design dispute puts Brexit IP transition under scrutiny

2 weeks ago | juve-patent.com | Mathieu Klos

From an IP perspective, the Brexit-related turmoil in the UK IP courts has largely subsided. The courts have established a new role, particularly in patent cases. Other geopolitical issues now dominate discussions in the UK capital. Today, however, the Court of Appeal will hear a case between Praesidiad and Zaun that has become entangled in the Brexit saga. It may be one of the last times a UK court acts as an EU IP court (case ID: CA-2024-001795). Wrong timingThe case began in March 2018.
QuantifiCare wins injunction against Canfield in 3D imaging dispute

2 weeks ago | juve-patent.com | Mathieu Klos

QuantifiCare accuses US competitor Canfield of infringing EP 3 156 843 with its Vectra H2 device. The French provider of imaging solutions in medicine filed suit at the Regional Court Düsseldorf. In early April, the court’s 4a Civil Chamber ruled that Canfield’s device infringes QuantifiCare’s patent. The court under presiding judge Tilmann ordered the German and US subsidiaries of Canfield to cease distribution of the product in Germany (case ID: 4a O 78/20).
Janssen appeals to Supreme Court after Samsung Bioepis win in SPC waiver case

4 weeks ago | juve-patent.com | Mathieu Klos

In February, the Dutch Court of Appeal under presiding judge J.I. de Vreese-Rood upheld a District Court judgment in PI proceedings between Janssen and Samsung Bioepis (case ID: 200.337.844/01). At the heart of the case was the interpretation of the EU regulation regarding the exemption for manufacturing pharmaceuticals for export to third countries, known as the SPC waiver. To date, European courts have seen little case law on this matter.
Ones to Watch UK 2025: Edmund Eustace

1 month ago | juve-patent.com | Mathieu Klos

Every year, JUVE Patent carries out extensive research in the UK patent market, culminating in the publication of the UK patent ranking. Our latest research highlighted Edmund Eustace, a barrister from 8 New Square as one of the current ‘Ones to Watch’ in the UK patent market. Edmund Eustace’s route to SEP litigation had been mapped out for several years.